Characteristics of Female Sex Workers in Southern India Willing and Unwilling to Participate in a Placebo Gel Trial
- 186 Downloads
Respondent-driven sampling was used to recruit female sex workers (FSWs) for a community survey conducted in southern India. After survey completion, participants were given a brochure describing a clinical trial that entailed daily use of a placebo vaginal gel for four months. This study assessed predictors of screening among survey respondents, predictors of enrollment among those eligible for the trial, and predictors of visit attendance and retention among those enrolled. FSWs who reported having symptoms of sexually transmitted infections (STI), engaging in sex work in the past month, and living in a subdistrict easily accessible by public transportation with a high concentration of FSWs, were more likely to screen. FSWs who had never been tested for HIV were more likely to enroll. This analysis suggests that the primary reason FSWs participated in the trial was a desire for health care—not other factors hypothesized to be important, e.g., HIV risk perception and poverty status.
KeywordsMicrobicides Willingness to participate Female sex workers Southern India
Funding for this research was provided by the Office of Population and Reproductive Health, Bureau for Global Health, United States Agency for International Development (USAID), Award Number GPO-A-00-04-00019; by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant No. R21-HD060270; and by the Indian Council of Medical Research (ICMR), Award No. Indo-US/54/2007-ECD II. The contents of this manuscript are solely the responsibility of the authors and do not necessarily reflect the views of USAID, NICHD or ICMR.
- 2.Hendrix CW, Minnis A, Guddera V, et al. MTN-001: a Phase 2 cross-over study of daily oral and vaginal TFV in healthy, sexually active women results in significantly different product acceptability and vaginal tissue drug concentrations. Conference on retroviruses and opportunistic infections; Boston, 2011.Google Scholar
- 17.Koblin B, Holte S, Lenderking B, Heagerty P, For the HIVNET vaccine preparedness study protocol team. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. J Acquir Immune Defic Syndr. 2000;24(5):451–7.PubMedGoogle Scholar
- 20.Tarimo EA, Thorson A, Bakari M, Mwami J, Sandstrom E, Kulane A. Willingness to volunteer in a phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania. Glob Health Action. 2009;2:1–7.Google Scholar
- 24.Fincham D, Kagee A, Swartz L. Inhibitors and facilitators of willingness to participate (WTP) in an HIV vaccine trial: construction and initial validation of the Inhibitors and facilitators of willingness to participate scale (WPS) among women at risk for HIV infection. AIDS Care. 2010;22(4):452–61.PubMedCrossRefGoogle Scholar
- 25.Tharawan K, Manopaiboon C, Ellertson C, et al. Women’s willingness to participate in microbide trials in northern Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 2001;28(2):180–6.Google Scholar
- 28.Ma M, Kibler JL, Vigil-Otero A, Sarpong D, Lally M, Mayer KH. Correlates of willingness to participate in microbicide research among African Americans. J Health Psychol. 2012; Feb 24 [Epub ahead of print].Google Scholar
- 29.van de Wijgert J, Coetzee N, de Kock A, Blanchard K, Jones H. Assessing selection bias in a microbicide trial. Poster presentation at the international congress of sexually transmitted infections—ISSTDR/IUSTI, Berlin,June 2001.Google Scholar
- 31.NACO. HIV Sentinel Surveillance and HIV Estimation in India 2007: a technical brief. New Delhi: National AIDS Control Organisaion, Ministry of Health and Family Welfare, Government of India. October 2008.Google Scholar
- 32.NACO. HIV Fact Sheets: based on HIV Sentinel Surveillance Data in India 2003–2006. New Delhi: National AIDS Control Organisation, Ministry of Health and Family Welfare. November 2007.Google Scholar
- 35.Tun W, Sarna A, Apicella L, Bhattacharya A. Recruitment of injecting drug users in two cities in India using respondent driven sampling for an HIV-related behavioral survey. In: 2nd international conference on surveying health in complex situations, 4 June 2007, University of Louvain, Belgium.Google Scholar
- 38.Tun W, Katzen LL, Abbott SA, et al. Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India). 2011. Unpublished.Google Scholar
- 39.Abbott SA, Friedland BA, Sarna A, et al. An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India. 2011. Unpublished.Google Scholar
- 41.Woodsong C, Alleman P, Musara P, et al. Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe. AIDS Behav. 2011. doi: 10.1007/s10461-011-0027-7.
- 42.Microbicide Trials Network (MTN). Expanded safety and acceptability study of a non-medicated intravaginal ring. Microbicide trials network. http://www.mtnstopshiv.org/studies/72. Accessed 30 March 2012.
- 46.FHI. FHI statement on the FEM-PrEP HIV prevention study http://minilicious.wordpress.com/2011/04/18/fhi-statement-on-the-fem-prep-hiv-prevention-study. Accessed 20 July 2011.
- 47.Microbicide Trials Network (MTN). MTN statement on decision to discontinue use of oral tenofovir tablets in VOICE, a major HIV prevention study in women. http://www.mtnstopshiv.org/node/3619 .Accessed 14 Oct 2011.
- 48.Thigpen MC, Kaebaabetswe PM, Smith DK, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study. Presentation given at international AIDS society conference, 17–20 July 2011, Rome. Oral abstract WELBC01.Google Scholar
- 49.Baeten J, Celum C, on behalf of the partners PrEP study team. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the Partners PrEP Study. Presentation given at International AIDS Society conference. 17–20 July 2011, Rome. Oral Abstract MOAX0106.Google Scholar